Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study.

Sumiyoshi T, Park S, Jayathilake K, Roy A, Ertugrul A, Meltzer HY
Schizophr Res. 2007 95 (1-3): 158-68

PMID: 17628435 · DOI:10.1016/j.schres.2007.06.008

MeSH Terms (19)

Adult Ambulatory Care Antipsychotic Agents Buspirone Cognition Disorders Double-Blind Method Drug Therapy, Combination Female Humans Isoindoles Male Neuropsychological Tests Piperazines Placebos Pyrimidines Schizophrenia Schizophrenic Psychology Serotonin Receptor Agonists Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links